Multiomic characterization of RCC1 expression and its association with molecular alterations, immune phenotypes, and cancer outcomes | Caris Life Sciences
Portal
Order
Home / Research / Publications / Multiomic characterization of RCC1 expression and its association with molecular alterations, immune phenotypes, and cancer outcomes

Publications

Back

Multiomic characterization of RCC1 expression and its association with molecular alterations, immune phenotypes, and cancer outcomes

– Caris Life Sciences

Poster

Conclusions

  • RCC1 expression is a negative prognostic marker in NSCLC, PC, and CRC
  • Further studies to investigate this at the molecular level may be a potential opportunity for novel targeted drug development
Download Publication

Discover
More

  • Racial differences in the molecular landscape of breast

    – Caris Life Sciences

    Poster

    Background: African Americans (AA) have a higher mortality associated with breast cancer when compared to Caucasians (C).This has been attributed to diverse factors that include… […]
Learn More

Ready to Get Started on the Journey?

Name(Required)